Research Articles
Double Trouble for Tough Tumors: How a New Molecular Team-Up Fights Triple Negative Breast Cancer
Novel endoxifen-based PROTAC molecules synergize with olaparib to fight triple negative breast cancer through induction of DNA damage
Breaking the Shield: How RAD6 Inhibition Makes Triple-Negative Breast Cancer Vulnerable to Therapy
Discover how RAD6 inhibition sensitizes triple-negative breast cancer to platinum-based therapy, offering new hope for TNBC patients.
The Nucleolus Unmasked: How a Cellular Factory Became Cancer's Achilles Heel
Groundbreaking research reveals the nucleolus plays a critical role in triple-negative breast cancer (TNBC) and how innovative tools like the Auxin-Inducible Degron system are uncovering new therapeutic targets.